SCHEMBL3358698

SCHEMBL3358698

CCOC1CCC(C(=O)Oc2ccc(C=CC(=O)O)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.48
ATM Q13315 1/20 0.48
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
GAA P10253 3/20 0.46
KMT2A Q03164 4/20 0.44
HTT P42858 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
ELANE P08246 1/20 0.44
POLB P06746 1/20 0.44
HPGD P15428 1/20 0.43
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.40
PGR P06401 1/20 0.40
ESR2 Q92731 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3358696 1.00 THRB (0.48) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3360421 0.92 THRB (0.45) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3360416 0.92 THRB (0.45) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3359918 0.91 THRB (0.44) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3359913 0.91 THRB (0.44) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3356914 0.89 THRB (0.42) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3356918 0.89 THRB (0.42) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3358501 0.88 THRB (0.41) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3358581 0.88 THRB (0.41) THRBATMNPC1RAB9ASMN1; SMN2
SCHEMBL3356890 0.88 THRB (0.41) THRBATMNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group ROLIC AG (CH) 2019-02-19 US disclosed
EP-2152660-B1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2016-05-11 EP disclosed
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2010-02-25 US disclosed
EP-2152660-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP Rolic AG (CH) 2010-02-17 EP disclosed
WO-2008145225-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group DDC, ALAD, DYNC1LI1 THRB 4854/4885ATM 2265/4885NPC1 4710/4885
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP DDC, ALAD, DYNC1LI1 THRB 4854/4885ATM 2265/4885NPC1 4710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.